INDUCTION OF NEPHROSIS BY β-CYCLODEXTRIN IN BEAGLES

The present study was conducted to examine nephrotoxicity of β-cyclodextrin (β-C) in dogs. Five female Beagle dogs were divided into 3 groups: Group 1 (2 dogs treated with 0.9g/kg of β-C), Group 2 (2 dogs treated with 0.45g/kg of β-C), and Group 3 (1 dog treated with saline). Durations of β-C inject...

Full description

Saved in:
Bibliographic Details
Published inJournal of Toxicologic Pathology Vol. 4; no. 1; pp. 67 - 73
Main Authors Okajima, Eigoro, Yamaguchi, Hisako, Kitahori, Yoshiteru, Hiasa, Yoshio, Matsuki, Hisashi, Hirao, Yoshihiko, Uemura, Hirotsugu, Samma, Shoji, Ozono, Seiichiro, Kitagawa, Hisayo, Tabata, Shoichi
Format Journal Article
LanguageEnglish
Published JAPANESE SOCIETY OF TOXICOLOGIC PATHOLOGY 1991
Subjects
Online AccessGet full text
ISSN0914-9198
1881-915X
DOI10.1293/tox.4.67

Cover

More Information
Summary:The present study was conducted to examine nephrotoxicity of β-cyclodextrin (β-C) in dogs. Five female Beagle dogs were divided into 3 groups: Group 1 (2 dogs treated with 0.9g/kg of β-C), Group 2 (2 dogs treated with 0.45g/kg of β-C), and Group 3 (1 dog treated with saline). Durations of β-C injection were 7 and 10 consecutive days in Groups 1 and 2. Histopathological and histo-chemical examinations of the kidney were performed. Following 0.9g/kg or long-term 0.45g/kg treatment with β-C, the animals showed marked fatigue and elevated BUN and Cr. Histopathologically, β-C treatment resulted in vacuolation, necrosis, and regeneration in the proximal tubules. Activities of succinic dehydrogenase, β-glucuronidase, and glucose-6-phosphatase decreased histochemically after β-C treatment. Because signs of nephrotoxicity represented were noted in dogs after β-C treatment, as has been reported in rats, it seems likely that dogs also can serve as a model of nephrosis. If this model is to be applied to the study of renal carcinogenesis, the present study suggests the optimum dosing regimen for β-C to be 7-day 0.45g/kg treatment.
ISSN:0914-9198
1881-915X
DOI:10.1293/tox.4.67